Korro Bio, Inc.KRRONASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-88.34M
↓ 83% below average
Average (7y)
$-48.32M
Historical baseline
Range
High:$-17.93M
Low:$-88.34M
CAGR
+24.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-88.34M | -9.2% |
| 2023 | $-80.90M | -43.2% |
| 2022 | $-56.49M | +29.4% |
| 2021 | $-80.07M | -221.6% |
| 2020 | $-24.90M | -38.8% |
| 2019 | $-17.93M | +2.6% |
| 2018 | $-18.41M | +5.8% |
| 2017 | $-19.53M | - |